Who Exports Ambroxol from India — 296 Suppliers Behind a $14.8M Market
India's ambroxol export market is supplied by 296 active exporters who collectively shipped $14.8M across 1,705 shipments. WEXFORD LABORATORIES PRIVATE LIMITED leads with a 13.7% market share, followed by LINCOLN PHARMACEUTICALS LTD and BIOMATRIX HEALTHCARE PRIVATE LIMITED. The top 5 suppliers together control 40.8% of total export value, reflecting a moderately competitive market structure.
Top Ambroxol Exporters from India — Ranked by Export Value
WEXFORD LABORATORIES PRIVATE LIMITED is the leading ambroxol exporter from India, holding a 13.7% share of the $14.8M market across 1,705 shipments from 296 exporters. The top 5 suppliers — WEXFORD LABORATORIES PRIVATE LIMITED, LINCOLN PHARMACEUTICALS LTD, BIOMATRIX HEALTHCARE PRIVATE LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED, SAVA HEALTHCARE LIMITED — collectively control 40.8% of total export value, indicating a competitive market. Individual shares are: WEXFORD LABORATORIES PRIVATE LIMITED (13.7%), LINCOLN PHARMACEUTICALS LTD (7.8%), BIOMATRIX HEALTHCARE PRIVATE LIMITED (7.3%), FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED (6.5%), SAVA HEALTHCARE LIMITED (5.5%).
Top Ambroxol Exporters from India
Ranked by export value · 296 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | WEXFORD LABORATORIES PRIVATE LIMITED AMBROXOL SYRUP 15MG/5ML - EXPECTUSS - 12AMBROXOL JBE AD 30MG/5MLX100ML(AMBROXOL HYDROCHLORIDE SYRUP 30 MG/5 ML | $2.0M | 4 | 13.7% |
| 2 | LINCOLN PHARMACEUTICALS LTD AMBROXOL HYDROCHLORIDE SYRUP (AMBROXOL HYDROCHLORIDE BP 30 MG + CETIRIAMBRODIL SYRUP AMBROXOL HY | $1.1M | 4 | 7.8% |
| 3 | BIOMATRIX HEALTHCARE PRIVATE LIMITED AMBROXOL HYDROCHLORIDE SYRUP (AMBROXOL HYDROCHLORIDE SYRUP 30MG/5ML (MAMBRODIL SYRUP AMBROXOL HY | $1.1M | 4 | 7.3% |
| 4 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED AMBROXOL HYDROCHLORIDE SYRUP (AMBROXOL HYDROCHLORIDE BP 30 MG + CETIRISYRUP OF AMBROXOL WITH CETRIZINE (AMBCET | $958.0K | 4 | 6.5% |
| 5 | SAVA HEALTHCARE LIMITED | $818.9K | 3 | 5.5% |
| 6 | SANPRAS HEALTHCARE PRIVATE LIMITED AMBROXOL JBE AD 30MG/5MLX100ML(AMBROXOL HYDROCHLORIDE SYRUP 30 MG/5 MLAMBROXOL JBE AD 30MG/5ML X100ML( | $551.0K | 1 | 3.7% |
| 7 | GRACURE PHARMACEUTICALS LIMITED AMBROXOL HYDROCHLORIDE BP 30 MG + CETIRIOLESOM (AMBROXOL HYDROCHLORIDE SYRUP 30OLESOMAMBROXOL HYDROCHLORIDE SYRUP 30 MG/5ML 100ML/ BTL | $470.8K | 2 | 3.2% |
| 8 | MEDICO REMEDIES LIMITED | $351.1K | 1 | 2.4% |
| 9 | ARISTO PHARMACEUTICALS PRIVATE LIMITED AMBROXOL HYDROCHLORIDE SYRUP (AMBROXOL HYDROCHLORIDE BP 30 MG + CETIRISYRUP OF AMBROXOL WITH CETRIZINE (AMBCET | $320.1K | 6 | 2.2% |
| 10 | S K AGE EXPORTS AMBROXOL SYRUP 15MG/5ML - EXPECTUSS - 12AMBROXOL HYDROCHLORIDE SYRUP (AMBROXOL HYDROCHLORIDE SYRUP 30MG/5ML (M | $301.4K | 6 | 2.0% |
| 11 | CAPLIN POINT LABORATORIES LIMITED | $281.6K | 6 | 1.9% |
| 12 | SERENE HEALTH CARE PRIVATE LIMITED | $258.6K | 2 | 1.7% |
| 13 | SAGA LIFESCIENCES LIMITED AMBROXOL HYDROCHLORIDE SYRUP 30MG/5ML (EAMBROXOL HYDROCHLORIDE SYRUP 15MG/5MLAMBROXOL HYDROCHLORIDE SYRUP 15 MG/5 ML | $241.9K | 4 | 1.6% |
| 14 | AGIO PHARMACEUTICALS LIMITED | $241.6K | 2 | 1.6% |
| 15 | VANCE AND HEALTH PHARMACEUTICALS PRIVATE LIMITED AMBROXOL HCL BP 15MG/5ML | $221.0K | 1 | 1.5% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ambroxol exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | Not Listed | Yes, as of October 2 | Yes | Not verified | WHO-GMP certified; EU GMP compliant as per MHRA records. |
| SAVA HEALTHCARE LIMITED | Not Listed | Yes, as of July 2025 | Not Listed | Not verified | WHO-GMP certified; facility accredited by various regulatory bodies. |
| AGIO PHARMACEUTICALS LIMITED | Not Listed | Yes, as of February | Not Listed | Not verified | WHO-GMP certified; application status recorded by Pharmexcil. |
TransData Nexus reviewed the regulatory standing of 3 leading Ambroxol exporters from India. 0 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ambroxol sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% to the nation's bulk drug production. The city hosts a robust ecosystem of pharmaceutical companies specializing in active pharmaceutical ingredients (APIs) and intermediates. Notable firms include A.R. Life Sciences, recognized for manufacturing high-quality APIs and intermediates, and Hy-Gro Chemicals, which focuses on cost-effective API development and manufacturing. This concentration of bulk drug manufacturers positions Hyderabad as a strategic sourcing hub for Ambroxol APIs.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Vadodara, in particular, is home to numerous pharmaceutical companies specializing in formulations and biogenerics. (mediaindia.eu) Companies like Alembic Pharmaceuticals, headquartered in Vadodara, manufacture and market a wide range of pharmaceutical products, including formulations for various therapeutic areas. This region's focus on formulations makes it a key area for sourcing finished Ambroxol products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a pivotal export gateway for pharmaceutical products. Mumbai, being a major port city, facilitates the export of pharmaceuticals to various international markets. Companies like Formel Labs, with facilities in Mumbai, are committed to producing safe and effective medicines, ensuring that products meet international standards. This region's strategic location and infrastructure support efficient distribution of Ambroxol products to global destinations.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, largely due to favorable tax incentives. This area hosts numerous pharmaceutical companies that benefit from these incentives, making it an attractive zone for cost-effective production. While specific data on Ambroxol production in this region is limited, the overall manufacturing capabilities suggest potential sourcing opportunities.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance standards of suppliers in Hyderabad for APIs and in Ahmedabad-Vadodara for formulations.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad region to streamline international distribution of Ambroxol products.
- Consider Cost Advantages: Explore sourcing from the Baddi-Nalagarh region to take advantage of tax incentives and potentially lower production costs.
Common Questions — Ambroxol Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ambroxol supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, WEXFORD LABORATORIES PRIVATE LIMITED leads with 28 recorded shipments worth $2.0M. LINCOLN PHARMACEUTICALS LTD (6 shipments) and BIOMATRIX HEALTHCARE PRIVATE LIMITED (24 shipments) are also established high-volume exporters.
Q How many ambroxol manufacturers are there in India?
India has 296 active ambroxol exporters with a combined export market of $14.8M across 1,705 shipments to 92 countries. The top 5 suppliers hold 40.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ambroxol from India?
Average FOB unit price: $2.18 per unit, ranging from $0.00 to $178.83. Average shipment value: $8.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 296 verified Indian exporters of Ambroxol ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,705 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 92 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,705 Verified Shipments
296 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists